OverviewChartNewsTraderScreen

Citi Discount Zert BAYN 25.06.202.../  DE000KJ2G183  /

EUWAX
31/05/2024  12:51:52 Chg.+0.68 Bid20:36:59 Ask20:36:59 Underlying Strike price Expiration date Option type
27.37EUR +2.55% 27.45
Bid Size: 1,500		 -
Ask Size: -		 BAYER AG NA O.N. - EUR 25/06/2024 Call
GlobeNewswire 07:05 Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire 07:05 Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire 07:00 Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire 07:00 Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire 30/05 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire 30/05 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 29/05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28/05 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
TeleTrader 14/05 Bayer's sales in Q1 at €13.7 billion, down 4.3%
GlobeNewswire 02/05 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 18/04 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 16/04 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 11/04 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 09/04 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 25/03 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 14/03 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 06/03 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 05/03 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 04/03 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 04/03 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 15/02 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 13/02 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 13/02 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
TeleTrader 29/01 Bayer down over 5% after latest $2.25B Roundup ruling
TeleTrader 17/01 Bayer to cut jobs amid 'difficult situation'